Clinical Trial Update: Risk Burden of Lipoprotein Metabolic Gene Haplotypes

View source ↗

Summary

This document reports on a completed clinical trial evaluating how lipoprotein metabolic gene haplotypes influence cardiovascular disease risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease
• Coronary Artery Disease
• Heart Disease

Snippet

Sponsor: Intermountain Health Care, Inc. | Conditions: Atherosclerosis, Cardiovascular Diseases | Status: COMPLETED